name: Dynamic adjustable finger flexion only device, includes soft interface material


name: Dynamic adjustable toe extension only device, includes soft interface material


name: Dynamic adjustable toe flexion only device, includes soft interface material


name: Suction pump, home model, portable or stationary, electric, any type, for use with external urine and/or fecal management system


name: Home blood glucose monitor for use with integrated lancing/blood sample testing cartridge


name: Complex rehabilitative power wheelchair accessory, power seat elevation system, any type


name: Accessory for speech generating device, electromyographic sensor


name: Gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components and accessories, prescription only


name: Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga


name: Management of new patient-caregiver dyad with dementia, low complexity, for use in cmmi model


name: Management of new patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model


name: Management of new patient-caregiver dyad with dementia, high complexity, for use in cmmi model


name: Management of a new patient with dementia, low complexity, for use in cmmi model


name: Management of a new patient with dementia, moderate to high complexity, for use in cmmi model


name: Management of established patient-caregiver dyad with dementia, low complexity, for use in cmmi model


name: Management of established patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model


name: Management of established patient-caregiver dyad with dementia, high complexity, for use in cmmi model


name: Management of established patient with dementia, low complexity, for use in cmmi model


name: Management of established patient with dementia, moderate to high complexity, for use in cmmi model


name: In-home respite care, 4-hour unit, for use in cmmi model


name: Adult day center, 8-hour unit, for use in cmmi model


name: Facility-based respite, 24-hour unit, for use in cmmi model


name: Take-home supply of nasal nalmefene hydrochloride; one carton of two, 2.7 mg per 0.1 ml nasal sprays (provision of the services by a medicare-enrolled opioid treatment program);( list separately in addition to each primary code)


name: Medication assisted treatment, buprenorphine (injectable) administered on a weekly basis; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)


name: Coordinated care and/or referral services, such as to adequate and accessible community resources to address unmet health-related social needs, including harm reduction interventions and recovery support services a patient needs and wishes to pursue, which significantly limit the ability to diagnose or treat an opioid use disorder; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)


name: Patient navigational services, provided directly or by referral; including helping the patient to navigate health systems and identify care providers and supportive services, to build patient self-advocacy and communication skills with care providers, and to promote patient-driven action plans and goals; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)


name: Peer recovery support services, provided directly or by referral; including leveraging knowledge of the condition or lived experience to provide support, mentorship, or inspiration to meet oud treatment and recovery goals; conducting a person-centered interview to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes; developing and proposing strategies to help meet person-centered treatment goals; assisting the patient in locating or navigating recovery support services; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)


name: Administration of a standardized, evidence-based atherosclerotic cardiovascular disease (ascvd) risk assessment, 5-15 minutes, not more often than every 12 months


name: Atherosclerotic cardiovascular disease (ascvd) risk management services; clinical staff time; per calendar month


name: Caregiver training in behavior management/modification for caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face; initial 30 minutes


name: Caregiver training in behavior management/modification for parent(s)/guardian(s)/caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face; each additional 15 minutes


name: Caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face; initial 30 minutes


name: Caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face; each additional 15 minutes (list separately in addition to code for primary service) (use g0542 in conjunction with g0541)


name: Group caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face with multiple sets of caregivers


name: Post discharge telephonic follow-up contacts performed in conjunction with a discharge from the emergency department for behavioral health or other crisis encounter, 4 calls per calendar month


name: Visit complexity inherent to hospital inpatient or observation care associated with a confirmed or suspected infectious disease by an infectious diseases specialist, including disease transmission risk assessment and mitigation, public health investigation, analysis, and testing, and complex antimicrobial therapy counseling and treatment (add-on code, list separately in addition to hospital inpatient or observation evaluation and management visit, initial, same day discharge, subsequent or discharge)


name: Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 5-10 minutes of medical consultative discussion and review


name: Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 11-20 minutes of medical consultative discussion and review


name: Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 21-30 minutes of medical consultative discussion and review


name: Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 31 or more minutes of medical consultative discussion and review


name: Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a written report to the patient's treating/requesting practitioner, 5 minutes or more of medical consultative time


name: Interprofessional telephone/internet/electronic health record referral service(s) provided by a treating/requesting practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, 30 minutes


name: Supply of digital mental health treatment device and initial education and onboarding, per course of treatment that augments a behavioral therapy plan


name: First 20 minutes of monthly treatment management services directly related to the patient's therapeutic use of the digital mental health treatment (dmht) device that augments a behavioral therapy plan, physician/other qualified health care professional time reviewing information related to the use of the dmht device, including patient observations and patient specific inputs in a calendar month and requiring at least one interactive communication with the patient/caregiver during the calendar month


name: Each additional 20 minutes of monthly treatment management services directly related to the patient's therapeutic use of the digital mental health treatment (dmht) device that augments a behavioral therapy plan, physician/other qualified health care professional time reviewing data generated from the dmht device from patient observations and patient specific inputs in a calendar month and requiring at least one interactive communication with the patient/caregiver during the calendar month


name: Provision of replacement patient electronics system (e.g., system pillow, handheld reader) for home pulmonary artery pressure monitoring


name: Advanced primary care management services for a patient with one chronic condition [expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline], or fewer, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month


name: Advanced primary care management services for a patient with multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month


name: Advanced primary care management services for a patient that is a qualified medicare beneficiary with multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month


name: Post-operative follow-up visit complexity inherent to evaluation and management services addressing surgical procedure(s), provided by a physician or qualified health care professional who is not the practitioner who performed the procedure (or in the same group practice) and is of the same or of a different specialty than the practitioner who performed the procedure, within the 90-day global period of the procedure(s), once per 90-day global period, when there has not been a formal transfer of care and requires the following required elements, when possible and applicable: reading available surgical note to understand the relative success of the procedure, the anatomy that was affected, and potential complications that could have arisen due to the unique circumstances of the patient's operation. research the procedure to determine expected post-operative course and potential complications (in the case of doing a post-op for a procedure outside the specialty). evaluate and physically examine the patient to determine whether the post-operative course is progressing appropriately. communicate with the practitioner who performed the procedure if any questions or concerns arise. (list separately in addition to office/outpatient evaluation and management visit, new or established)


name: Safety planning interventions, each 20 minutes personally performed by the billing practitioner, including assisting the patient in the identification of the following personalized elements of a safety plan: recognizing warning signs of an impending suicidal or substance use-related crisis; employing internal coping strategies; utilizing social contacts and social settings as a means of distraction from suicidal thoughts or risky substance use; utilizing family members, significant others, caregivers, and/or friends to help resolve the crisis; contacting mental health or substance use disorder professionals or agencies; and making the environment safe


name: Tympanostomy with local or topical anesthesia and insertion of a ventilating tube when performed with tympanostomy tube delivery device, unilateral (list separately in addition to 69433) (do not use in conjunction with 0583t)


name: Interprofessional telephone/internet/electronic health record clinical question/request for specialty recommendations by a treating/requesting physician or other qualified health care professional for the care of the patient (i.e. not for professional education or scheduling) and may include subsequent follow up on the specialist's recommendations; 30 minutes


name: Co-management services with the following elements: new diagnosis or acute exacerbation and stabilization of existing condition; condition which may benefit from joint care planning; condition for which specialist is taking a co-management role; condition expected to last at least 3 months; comprehensive care plan established, implemented, revised or monitored in partnership with co-managing clinicians; ongoing communication and care coordination between co-managing clinicians furnishing care


name: Missing and murdered indigenous persons (mmip) mental health and clinical care


name: Historical trauma (ht) mental health and clinical care for indigenous persons


name: Docking station for use with oral device/appliance used to reduce upper airway collapsibility


name: Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla to trochanter, includes all accessory pads, straps and interface, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise


name: Thoracic, pectus carinatum orthosis, sternal compression, rigid circumferential frame with anterior and posterior rigid pads, custom fabricated


name: Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, off the shelf


name: Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated, off the shelf


name: Addition to lower extremity, user adjustable, mechanical, residual limb volume management system


name: Addition, endoskeletal knee-shin system, polycentric, pneumatic swing, and stance phase control


name: External lower extremity sensory prosthetic device, cutaneous stimulation of mechanoreceptors proximal to the ankle, per leg


name: Receptor sole for use with l8720, replacement, each


name: Quality care for patients with neurological conditions mips value pathway


name: Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring


name: Recommended follow-up interval for repeat colonoscopy of 10 years documented in colonoscopy report and communicated with patient


name: Complete ophthalmologic care mips value pathway


name: Gastroenterology care mips value pathway


name: Optimal care for patients with urologic conditions mips value pathway


name: Red blood cells, leukocytes reduced, oxygen/ carbon dioxide reduced, each unit


name: Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription


name: Penile contracture device, manual, greater than 3 lbs traction force


name: Intra-vaginal motion sensor system, provides biofeedback for pelvic floor muscle rehabilitation device


name: Electrochemiluminescent immunoassay (ECLIA) of cerebral spinal fluid for B-amyloid (Abeta42) and phospho tau (181P) (pTau181) ratio reported as positive or negative for amyloid pathology


name: Oncology (lung and colon cancer), DNA, qualitative, next-generation sequencing detection of single-nucleotide variants and deletions in EGFR and KRAS genes, formalin-fixed paraffin-embedded (FFPE) solid tumor samples, reported as presence or absence of targeted mutation(s), with recommended therapeutic options


name: Testing for B-amyloid and total tau in spinal fluid, ratio reported as positive or negative for amyloid pathology


name: Rheumatoid factor iga and igm, cyclic citrullinated peptide (ccp) antibodies, and scavenger receptor a (sr-a) by immunoassay, blood


name: Carbonic anhydrase vi, parotid specific/secretory protein and salivary protein 1 (sp1), igg, igm, and iga antibodies, chemiluminescence, semiqualitative, blood


name: Oncology (solid tumor), dna, qualitative, next-generation sequencing (ngs) of single-nucleotide variants (snv) and insertion/deletions in 22 genes utilizing formalin-fixed paraffin-embedded tissue, reported as presence or absence of mutation(s), location of mutation(s), nucleotide change, and amino acid change


name: Obstetrics (preeclampsia), sflt-1/plgf ratio, immunoassay, utilizing serum or plasma, reported as a value


name: Oncology, spheroid cell culture, 11-drug panel (carboplatin, docetaxel, doxorubicin, etoposide, gemcitabine, niraparib, olaparib, paclitaxel, rucaparib, topotecan, veliparib) ovarian, fallopian, or peritoneal response prediction for each drug


name: Nephrology (renal transplant), quantification of cxcl10 chemokines, flow cytometry, urine, reported as pg/ml creatinine baseline and monitoring over time


name: Herpes simplex virus (hsv) types 1 and 2 and varicella zoster virus (vzv), amplified probe technique, each pathogen reported as detected or not detected


name: Lower respiratory tract infectious agent detection, 18 bacteria, 8 viruses, and 7 antimicrobial-resistance genes, amplified probe technique, including reverse transcription for rna targets, each analyte reported as detected or not detected with semiquantitative results for 15 bacteria


name: Hematology (venous thromboembolism [vte]), genome-wide single-nucleotide polymorphism variants, including f2 and f5 gene analysis, and leiden variant, by microarray analysis, saliva, report as risk score for vte


name: Oncology (pan-solid tumor), ctdna, utilizing plasma, next-generation sequencing (ngs) of 77 genes, 8 fusions, microsatellite instability, and tumor mutation burden, interpretative report for single-nucleotide variants, copy-number alterations, with therapy association


name: percutaneous transluminal balloon angioplasty with insertion of stent into aorta (treatment)


name: percutaneous transluminal balloon angioplasty with insertion of stent into pulmonary artery (treatment)


name: Medical Subject Headings, 2025_2025_02_03


name: Online Mendelian Inheritance in Man, 2025_02_05


name: NAXE, (GGGCC)n REPEAT EXPANSION, PROMOTER


name: Crown, resin with predominantly base metal (procedure)


name: 16-item Transportation Security Index:-:Pt:^Patient:-:TSI-16


name: How often did you spend a long time waiting because you did not have the transportation that would allow you to come and go when you wanted:Find:30D:^Patient:Ord


name: How often did you spend a long time waiting because you did not have the transportation that would allow you to come and go when you wanted


name: How often you were late getting somewhere because of a problem with transportation:Find:30D:^Patient:Ord


name: How often you were late getting somewhere because of a problem with transportation


name: How often did it take you longer to get somewhere than it would have taken you if you had different transportation:Find:30D:^Patient:Ord


name: How often did it take you longer to get somewhere than it would have taken you if you had different transportation


name: How often did you have to arrive somewhere early and wait because of the schedule of the bus, train, or person giving you a ride:Find:30D:^Patient:Ord


name: How often did you have to arrive somewhere early and wait because of the schedule of the bus, train, or person giving you a ride


name: How often did you have to reschedule an appointment because of a problem with transportation:Find:30D:^Patient:Ord


name: How often did you have to reschedule an appointment because of a problem with transportation


name: How often did you skip going somewhere because of a problem with transportation:Find:30D:^Patient:Ord


name: How often did you skip going somewhere because of a problem with transportation


name: How often were you not able to leave the house when you wanted to because of a problem with transportation:Find:30D:^Patient:Ord


name: How often were you not able to leave the house when you wanted to because of a problem with transportation


name: How often did you worry about whether or not you would be able to get somewhere because of a problem with transportation:Find:30D:^Patient:Ord


name: How often did you worry about whether or not you would be able to get somewhere because of a problem with transportation


name: How often did you feel stuck at home because of a problem with transportation:Find:30D:^Patient:Ord


name: How often did you feel stuck at home because of a problem with transportation


name: How often do you think that someone did not invite you to something because of problems with transportation:Find:30D:^Patient:Ord


name: How often do you think that someone did not invite you to something because of problems with transportation


name: How often did you feel like friends, family, or neighbors were avoiding you because you needed help with transportation:Find:30D:^Patient:Ord


name: How often did you feel like friends, family, or neighbors were avoiding you because you needed help with transportation


name: How often did you feel left out because you did not have the transportation you needed:Find:30D:^Patient:Ord


name: How often did you feel left out because you did not have the transportation you needed


name: How often did you feel bad because you did not have the transportation you needed:Find:30D:^Patient:Ord


name: How often did you feel bad because you did not have the transportation you needed


name: How often did you worry about inconveniencing your friends, family, or neighbors because you needed help with transportation:Find:30D:^Patient:Ord


name: How often did you worry about inconveniencing your friends, family, or neighbors because you needed help with transportation


name: How often did problems with transportation affect your relationships with others:Find:30D:^Patient:Ord


name: How often did problems with transportation affect your relationships with others


name: How often did you feel embarrassed because you did not have the transportation you needed:Find:30D:^Patient:Ord


name: How often did you feel embarrassed because you did not have the transportation you needed


name: Egg Comprehensive Antibody.immunoglobulin E panel


name: Guidance for aspiration of ganglion cyst:Find:Pt:XXX:Doc:US


name: Guidance for aspiration of ganglion cyst


name: Continuous glucose monitor device:TmStp:RptPeriod^start:^Patient:Qn:Reported


name: Continuous glucose monitor device:TmStp:RptPeriod^end:^Patient:Qn:Reported


name: Days continuous glucose monitor device worn:Num:RptPeriod:^Patient:Qn:Estimated


name: Percentage of time continuous glucose monitor device worn:TimeFr:RptPeriod:^Patient:Qn:Calculated


name: Time above range, very high:TimeFr:RptPeriod:Interstitial fluid:Qn:Calculated


name: Time above range, high:TimeFr:RptPeriod:Interstitial fluid:Qn:Calculated


name: Time below range, low:TimeFr:RptPeriod:Interstitial fluid:Qn:Calculated


name: Time below range, very low:NFr:RptPeriod:Interstitial fluid:Qn:Calculated


name: Tumor cells+Macrophages+Lymphocytes.Programmed cell death ligand 1/Viable tumor cells


name: Tumor cells.Programmed cell death ligand 1/Viable tumor cells


name: Guidance for placement of non-tunneled central venous catheter:Find:Pt:Head+Neck>Jugular vein.unilateral:Doc:US


name: Three-Item Loneliness scale:-:Pt:^Patient:-:Three-Item Loneliness Scale


name: Total score:Score:Pt:^Patient:Qn:Three-Item Loneliness Scale


name: 6-item Transportation Security Index:-:Pt:^Patient:-:TSI-6


name: Botulinum neurotoxin producing species:Prid:Pt:Isolate:Nom:Endopep-MS


name: TGFBR3 & OGA gene rearrangements:Find:Pt:Tiss:Doc:FISH


name: Pediatric cancer survivorship summary:Find:Pt:^Patient:Doc


name: California encephalitis virus Ab.IgG & IgM:Find:Pt:CSF:Ord:IF


name: Human papilloma virus 16 mRNA:PrThr:Pt:Vag:Ord:Probe.amp.tar


name: Human papilloma virus 18+45 mRNA:PrThr:Pt:Vag:Ord:Probe.amp.tar


name: Is mother of advanced age:Find:Pt:^Patient:Ord


name: Annual salt bush Ab.IgE:ACnc:Pt:Ser/Plas:Qn:IA


name: t(14;19)(q32;q13) (IGH, BCL3):Find:Pt:Bld/Bone mar:Ord:FISH


name: Subepithelial autoimmune blistering disease panel:-:Pt:Ser/Plas:-


name: Subepithelial autoimmune blistering disease panel


name: Collagen type VII Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF


name: Myelin oligodendrocyte glycoprotein Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF


name: Clostridioides difficile toxin A DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Clostridioides difficile toxin B DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Clostridioides difficile toxin A+B DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Escherichia coli shiga-like toxin DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Herpes simplex virus 1 DNA:PrThr:Pt:Thrt:Ord:Probe.amp.tar


name: Herpes simplex virus 2 DNA:PrThr:Pt:Thrt:Ord:Probe.amp.tar


name: Ureaplasma urealyticum+Ureaplasma parvum DNA:PrThr:Pt:Thrt:Ord:Probe.amp.tar


name: Ureaplasma urealyticum+Ureaplasma parvum DNA:PrThr:Pt:Vag:Ord:Probe.amp.tar


name: Ureaplasma urealyticum+Ureaplasma parvum DNA:PrThr:Pt:Urine:Ord:Probe.amp.tar


name: Herpes simplex virus 2 DNA:PrThr:Pt:Anal:Ord:Probe.amp.tar


name: Ureaplasma urealyticum+Ureaplasma parvum DNA:PrThr:Pt:Anal:Ord:Probe.amp.tar


name: Monkeypox virus clade Ia DNA:PrThr:Pt:Specimen:Ord:Probe.amp.tar


name: Monkeypox virus clade Ib DNA:PrThr:Pt:Specimen:Ord:Probe.amp.tar


name: Bacteroides fragilis DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Candida albicans DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Candida auris DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Candida glabrata DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Candida krusei DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Candida parapsilosis DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Candida tropicalis DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Escherichia coli DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Klebsiella aerogenes DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Cryptococcus gattii+neoformans DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Enterobacter cloacae complex DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Enterococcus faecium DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Enterococcus faecalis DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Streptococcus agalactiae DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Haemophilus influenzae DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Klebsiella oxytoca DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Klebsiella pneumoniae DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Listeria monocytogenes DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Neisseria meningitidis DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Proteus sp DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Pseudomonas aeruginosa DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Staphylococcus epidermidis DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Serratia marcescens DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Staphylococcus aureus DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Staphylococcus lugdunensis DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Stenotrophomonas maltophilia DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Streptococcus pneumoniae DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Streptococcus pyogenes DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Streptococcus sp DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Staphylococcus sp DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Salmonella sp DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Acinetobacter calcoaceticus-baumannii complex DNA:PrThr:Pt:Body fld:Ord:Non-probe.amp.tar


name: Infectious pathogens panel:-:Pt:Body fld:-:Non-probe.amp.tar


name: SARS-CoV-2 ORF1ab + N gene:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Influenza B NEP gene:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Respiratory syncytial virus N gene:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Coagulation factor VIII activity actual/Normal:RelACnc:Pt:PPP:Qn:Bovine factor X substrate + Chromogenic


name: Parainfluenza virus 1+2+3+4 Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Month of first prenatal care visit:Time:Pt:^Patient:Qn


name: Tissue perfusion and oxygenation:Find:Pt:^Patient:Ord


name: Free from harm related to unintentional contamination of the sterile field and wound:Find:Pt:^Patient:Ord


name: Natriuretic peptide.B prohormone N-Terminal:MCnc:Pt:Ser/Plas/Bld:Qn:IA.rapid


name: Bacillus anthracis lethal factor Ab:PrThr:Pt:Ser:Ord:IA


name: HIV pre exposure prophylaxis monitoring panel:-:Pt:Ser/Plas:-


name: HIV pre exposure prophylaxis monitoring panel


name: Respiratory syncytial virus A+B N gene:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Hereditary thyroid cancer multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary thyroid cancer multigene analysis


name: Hereditary renal cancer multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary renal cancer multigene analysis


name: Hereditary pancreatic cancer multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary pancreatic cancer multigene analysis


name: Myelodysplastic neoplasm chromosome analysis:Find:Pt:Bld/Bone mar:Doc:FISH


name: Myelodysplastic neoplasm chromosome analysis


name: Membranous nephropathy associated antigens analysis:Find:Pt:Tiss:Doc:LC/MS/MS


name: Membranous nephropathy associated antigens analysis


name: Contactin-associated protein 1 Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: LDL receptor related protein 4 Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: Where was the pregnancy followed-up:Type:Pt:^Patient:Nom


name: Hours before delivery when membranes ruptured:Time:Pt:^Patient:Qn


name: Analytical tests in the third trimester of pregnancy:Find:Pt:^Patient:Ord


name: Analytical tests in the third trimester of pregnancy


name: Continuous glucose monitoring time in ranges panel:-:Pt:^Patient:-


name: Continuous glucose monitoring time in ranges panel


name: Peanut components allergen IgE panel:-:Pt:Ser:-:IA


name: Total Score:Score:Pt:^Animal:Qn:Feline grimace scale


name: Feline Grimace Scale Panel:-:Pt:^Animal:-:Feline grimace scale


name: Pupillary response:Find:Pt:Eye:Nom:Swinging light test


name: Coagulation factor XIII inhibitor:ACnc:Pt:PPP:Qn:Chromo


name: Cytomegalovirus UL56 gene mutations detected:Prid:Pt:Isolate:Nom


name: Arachis hypogaea recombinant Ab.IgE & IgD & IgG4 & IgA:Type:Pt:Ser/Plas:Ord:IA


name: PROMIS Item Bank v1.0 - Emotional Distress - Anxiety - Short Form 8a:-:Pt:^Patient:-:PROMIS


name: PROMIS Item Bank v1.0 - Emotional Distress - Anxiety - Short Form 8a


name: HIV1+2 Ab & Treponema pallidum Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid


name: Relapse after end of treatment:Imp:Pt:^Patient:Nar


name: How often have you found yourself thinking about things that you have to accomplish:Find:1Mo:^Patient:Ord


name: How often have you found yourself thinking about things that you have to accomplish


name: How often have you been able to control the way you spend your time:Find:1Mo:^Patient:Ord


name: How often have you been able to control the way you spend your time


name: How often have you felt that you were effectively coping with important changes that were occurring in your life:Find:1Mo:^Patient:Ord


name: How often have you felt that you were effectively coping with important changes that were occurring in your life


name: How often have you dealt successfully with day to day problems and annoyances:Find:1Mo:^Patient:Ord


name: How often have you dealt successfully with day to day problems and annoyances


name: Gram negative bacteria:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Colony forming unit granulocyte macrophage:NCnt:Pt:Bld:Qn


name: Colony forming unit granulocyte macrophage:NCnc:Pt:Hematopoietic progenitor cells^BPU:Qn


name: Colony forming unit granulocyte macrophage:NCnc:Pt:Bld:Qn:VC


name: Social or personal history:Find:Pt:^Patient:Nom


name: Did a current or former partner make you feel afraid that they might try to hurt you in some way:Find:1Y:^Patient:Ord


name: Did a current or former partner make you feel afraid that they might try to hurt you in some way


name: Did a current or former partner make you feel cut off from others, trapped, or controlled in a way you did not like:Find:1Y:^Patient:Ord


name: Did a current or former partner make you feel cut off from others, trapped, or controlled in a way you did not like


name: Intimate partner violence 4:-:1Y:^Patient:-:IPV-4


name: Did a current or former partner pressure or force you to do something sexual that you didn't want to do:Find:1Y:^Patient:Ord


name: Did a current or former partner pressure or force you to do something sexual that you didn't want to do


name: Did a current or former partner hit, kick, punch, slap, shove, or otherwise physically hurt you:Find:1Y:^Patient:Ord


name: Did a current or former partner hit, kick, punch, slap, shove, or otherwise physically hurt you


name: Hepatitis D virus Ab:PrThr:Pt:Ser/Plas:Ord:IA


name: Hepatitis B virus core Ab:ACnc:Pt:Ser/Plas:Qn:IA


name: Amyloid plaques probability score:Score:Pt:Plas:Nom:Calculation


name: Tau protein.phosphorylated 217/Tau protein.unphosphorylated 217:MRto:Pt:Plas:Qn:LC/MS/MS


name: Amyloid beta 42 peptide/Amyloid beta 40 peptide:MRto:Pt:Plas:Qn:LC/MS/MS


name: Human urine markers assessment:PrThr:Pt:Urine:Ord:Confirm


name: pH^^adjusted to eucapnic level:LsCnc:Pt:BldCoA:SemiQn:Calculated


name: Testis expressed Protein 101:MCnc:Pt:Semen:Qn:IA


name: Extracellular Matrix Protein 1:MCnc:Pt:Semen:Qn:IA


name: Medical device description panel:-:Pt:^Patient:-


name: Body mass index formula:Find:Pt:^Patient:Nar


name: PROMIS Pediatric Item Bank GenPop v3.0 - Depressive Symptoms - Short Form 8a:-:Pt:^Patient:-:PROMIS


name: PROMIS Pediatric Item Bank GenPop v3.0 - Depressive Symptoms - Short Form 8a


name: PROMIS pediatric depressive symptoms - version 3.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS Pediatric Item Bank GenPop v3.0 - Depressive Symptoms - Short Form 8a raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: Oxygen delivery additional details:Find:Pt:^Patient:Nar


name: Method of oxygen delivery:Find:Pt:^Patient:Nom


name: Waveform observation information panel:-:Pt:^Patient:-


name: SpO2 waveform sample period:Time:Pt:^Patient:Qn


name: SpO2 waveform scaling factor:Num:Pt:^Patient:Qn


name: Level of exertion information panel:-:Pt:^Patient:-


name: Medication dispense directions information panel:-:Pt:Medication:-


name: Medication dispense directions information panel


name: Multimedia object create date:Date:Pt:^Patient:Qn


name: General structured lab report:-:Pt:^Patient:-


name: Day of menstrual cycle:Find:Pt:^Patient:Ord


name: SpO2 preductal or postductal indicator:Find:Pt:^Patient:Nom


name: Mean arterial pressure formula:Find:Pt:^Patient:Nar


name: Medication safety information panel:-:Pt:Medication:-


name: Medication total daily effective dose purpose:Find:Pt:Medication:Nar


name: Medication total daily effective dose purpose


name: Inspired oxygen information panel:-:Pt:^Patient:-


name: Viable CD3 cells/cells.CD3:NFr:Pt:Hematopoietic progenitor cells^BPU:Qn


name: Viable CD45 cells/cells.CD45:NFr:Pt:Hematopoietic progenitor cells^BPU:Qn


name: CD45 dose:NCnt:Pt:Hematopoietic progenitor cells^BPU:Qn


name: Congenital heart disease screening:Find:Pt:^Newborn:Ord


name: Hyaline casts:NCnc:Pt:Urine sed:Qn:Automated count


name: Granular casts:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Erythrocyte casts:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Leukocyte casts:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Legionella sp:Prid:Pt:Asp:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Skin:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Semen:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Drain:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Abscess:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Amnio fld:Nom:Organism specific culture


name: Natriuretic peptide.B prohormone N-Terminal:MCnc:Pt:Body fld:Qn:IA


name: Casts type not specified:PrThr:Pt:Urine sed:Ord:Computer assisted


name: Platelets^in presence of EDTA to detect possible clumping:NCnc:Pt:Bld:Qn:Automated count


name: IgK Tube gene B length in base pairs:Num:Pt:XXX:Qn:Molgen


name: IgK Tube A length in base pairs:Num:Pt:XXX:Qn:Molgen


name: IgH FR3 length in base pairs:Num:Pt:XXX:Qn:Molgen


name: IgH FR2 length in base pairs:Num:Pt:XXX:Qn:Molgen


name: IgH FR1 length in base pairs:Num:Pt:XXX:Qn:Molgen


name: TCRB Tube gene C length in base pairs:Num:Pt:XXX:Qn:Molgen


name: TCRB Tube gene B length in base pairs:Num:Pt:XXX:Qn:Molgen


name: TCRB Tube gene A length in base pairs:Num:Pt:XXX:Qn:Molgen


name: TCRG Tube gene B length in base pairs:Num:Pt:XXX:Qn:Molgen


name: TCRG Tube gene A length in base pairs:Num:Pt:XXX:Qn:Molgen


name: Treponema pallidum Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Octamer binding transcription factor 3+4 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: NKX3.1 homeodomain transcription factor Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Microphthalmia-associated transcription factor 1 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: GATA binding protein 3 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: FLI-1 Oncoprotein Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: c-MYC Oncoprotein Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Amyloid Beta Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Natriuretic peptide.B^^adjusted for eGFR:MCnc:Pt:Ser/Plas:Qn


name: Sjogrens syndrome-A extractable nuclear 60kD Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: 1p & 19q chromosome deletion:Find:Pt:Tiss:Doc:FISH


name: Clonality analysis of Ig receptor genes:Find:Pt:XXX:Doc:Sequencing


name: Measurable residual disease analysis:Find:Pt:XXX:Ord:Sequencing


name: Tick borne encephalitis virus Ab:Imp:Pt:Ser/Plas:Nom


name: Rh antigens C little c E little e panel:-:Pt:RBC:-


name: Busulfan^5H post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Busulfan^3H post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Busulfan^15M post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Total number of doses:Num:Pt:^Patient:Qn


name: Test dose included in cumulative AUC:Find:Pt:^Patient:Ord


name: NUP98 11p15.4 gene rearrangement:Prid:Pt:Bld/Tiss:Nom:FISH


name: ASXL1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: CSF3R gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: CBL gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: CALR gene exon 9 targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: MPL gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: PDGFRA gene full mutation analysis:PrThr:Pt:Bld/Tiss:Ord:Sequencing


name: Guidance for percutaneous mechanical thrombectomy:Find:Pt:Chest>Pulmonary arteries.right:Doc:RF


name: Guidance for percutaneous mechanical thrombectomy


name: Guidance for percutaneous mechanical thrombectomy:Find:Pt:Chest>Pulmonary artery:Doc:RF


name: Guidance for percutaneous aspiration thrombectomy:Find:Pt:Lower extremity.left>Lower extremity artery:Doc:RF


name: Guidance for percutaneous aspiration thrombectomy


name: Guidance for embolization:Find:Pt:Head+Neck>Carotid arteries.left:Doc:RF


name: Guidance for embolization:Find:Pt:Head>Cerebral artery:Doc:RF.angio


name: Guidance for insertion of stent:Find:Pt:Head+Neck>Carotid arteries.right:Doc:RF.angio


name: Views:Find:Pt:Upper extremity.right>Wrist:Doc:XR && RF


name: Views:Find:Pt:Upper extremity.left>Wrist:Doc:XR && RF


name: Guidance for reposition of central venous catheter:Find:Pt:XXX:Doc:RF


name: Guidance for exchange of central venous catheter:Find:Pt:XXX:Doc:RF


name: Guidance for exchange of central venous catheter


name: Views:Find:Pt:Upper extremity.right:Doc:XR && RF


name: Views:Find:Pt:Upper extremity.left:Doc:XR && RF


name: Views:Find:Pt:Upper extremity.bilateral:Doc:XR && RF


name: Infusion start date and time:TmStp:Pt:^Patient:Qn


name: Infusion stop date and time:TmStp:Pt:^Patient:Qn


name: Busulfan area under the curve:TmMCnc:Stdy:Plas:Qn


name: Busulfan area under the curve.cumulative:TmMCnc:Stdy:Plas:Qn


name: Busulfan area under the curve.cumulative


name: Homologous recombination deficiency status analysis:Threshold:Pt:Tiss:Ord:Molgen


name: Homologous recombination deficiency status analysis


name: Candida species DNA panel:-:Pt:Bld:-:Probe.amp.tar


name: Guidance for embolization:Find:Pt:Chest>Pulmonary artery:Doc:RF


name: Guidance for radiofrequency ablation:Find:Pt:Chest>Spine.thoracic intercostal nerve:Doc:RF


name: Guidance for replacement of gastrojejunostomy tube:Find:Pt:Abdomen>Gastrointestinal tract.upper:Doc:RF


name: Guidance for replacement of gastrojejunostomy tube


name: Guidance for placement of stent graft:Find:Pt:Neck>Carotid artery.common.right:Doc:RF.angio


name: Guidance for placement of gastrojejunostomy tube:Find:Pt:Abdomen>Gastrointestinal tract.upper:Doc:RF


name: Guidance for embolization:Find:Pt:Head+Neck>Carotid artery.external:Doc:RF


name: Guidance for percutaneous transluminal angioplasty:Find:Pt:Abdomen+Pelvis>Iliac artery:Doc:RF


name: Guidance for percutaneous thrombectomy:Find:Pt:Head>Cerebral artery:Doc:RF


name: Caregiver follow-up goal attainment scaling score:Score:Pt:^Patient:Ord


name: Practitioner follow-up goal attainment scaling score:Score:Pt:^Patient:Ord


name: Patient follow-up goal attainment scaling score:Score:Pt:^Patient:Ord


name: PROMIS emotional distress anxiety version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: Breast cancer molecular subtype:Find:Pt:Tiss:Nom:Prosigna


name: Influenza virus A+B RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Herpes virus 7 DNA:PrThr:Pt:CSF:Ord:Probe.amp.tar


name: Herpes virus 6 DNA:PrThr:Pt:Ser/Plas:Ord:Probe.amp.tar


name: Microscopic observation:Prid:Pt:Stool:Nom:Acid fast stain.Kinyoun modified


name: Influenza virus B RNA:PrThr:Pt:Sputum:Ord:Non-probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Sputum:Ord:Non-probe.amp.tar


name: Human papilloma virus genotype:Prid:Pt:Semen:Nom:Probe.amp.tar


name: Common myeloid progenitor cell:Naric:Pt:Plas:Qn


name: von Willebrand factor activity.glycoprotein Ib gain of function (GPIbM):RelRto:Pt:PPP:Qn:Turbidimetry


name: von Willebrand factor activity.ristocetin cofactor (GPIbR) actual/Normal:RelRto:Pt:PPP:Qn:Turbidimetry


name: von Willebrand factor activity.ristocetin cofactor (GPIbR) actual/Normal


name: Ciliated columnar lining cells/Leukocytes


name: Spermatozoa.tail tip.motile with IgA/Spermatozoa


name: Spermatozoa.tail tip.motile with IgG/Spermatozoa


name: Spermatozoa.tail tip.motile with IgM/Spermatozoa


name: Cells.aneuploid.G2 phase population 2/Cells


name: Cells.aneuploid.S phase population 2/Cells


name: Cells.programmed cell death ligand 1/Viable tumor cells


name: Cells.HER2 uniform intense membrane staining/Cells


name: Cells.CD8.PMA+ionomycin stimulated CD107a+b expressing/Cells.CD3+CD8+


name: Cells.CD8.PMA+ionomycin stimulated gamma interferon producing/Cells.CD3+CD8+


name: Monocytes.programmed cell death ligand 1/Monocytes


name: How often have you been upset because of something that happened unexpectedly


name: How often have you felt that you were unable to control the important things in your life


name: Did problems with transportation affect your relationships with others


name: Yeast colony^with canavanine glycine+bromothymol blue


name: Yeast colony^with Sabouraud Dextrose Agar


name: Tau protein.phosphorylated 217/Tau protein.unphosphorylated 217


name: How often have you felt nervous and stressed


name: How often have you felt confident about your ability to handle your personal problems


name: How often have you felt that things were going your way


name: How often have you found that you could not cope with all the things that you had to do


name: How often have you been able to control irritations in your life


name: How often have you felt that you were on top of things


name: How often have you felt difficulties were piling up so high that you could not overcome them


name: Blood group antibody^post transfusion reaction


name: Cells.recipient derived/Cells^post stem cell transplantation


name: Spermatozoa.slow/Spermatozoa ^1H post ejaculation


name: Has the electric, gas, oil, or water company threatened to shut off services in your home


name: Creatinine, Cystatin C and Urea-based formula (CKiD)/1.73 sq M


name: Creatinine-based formula (MDRD)/1.73 sq M


name: Creatinine-based formula (Schwartz)/1.73 sq M


name: Creatinine-based formula (CKD-EPI)/1.73 sq M


name: Creatinine and Cystatin C-based formula (CKD-EPI)/1.73 sq M


name: Creatinine-based formula (CKD-EPI 2021)/1.73 sq M


name: Creatinine and Cystatin C-based formula (CKD-EPI 2021)/1.73 sq M


name: Colony count | Bronchoalveolar lavage | Microbiology


name: Colony count | Sputum tracheal aspirate | Microbiology


name: Amyloid beta 42 peptide/Amyloid beta 40 peptide | Plasma | Chemistry - non-challenge


name: Glomerular filtration rate | Blood | Chemistry - non-challenge


name: Glomerular filtration rate | DBS | Chemistry - non-challenge


name: Glomerular filtration rate | Serum or Plasma | Chemistry - non-challenge


name: Glomerular filtration rate | Serum, Plasma or Blood | Chemistry - non-challenge


name: Glomerular filtration rate | Urine and Serum or Plasma | Chemistry - non-challenge


name: Toxic substance | Urine | Drug toxicology


name: Drugs | Serum or Plasma | Drug toxicology


name: Drugs | Tissue and Smears | Drug toxicology


name: Drugs | Unknown substance | Drug toxicology


name: Drugs | Vitreous fluid | Drug toxicology


name: Benzodiazepines panel | Serum, Plasma or Blood | Drug and Toxicology Panels


name: Opiates panel | Urine | Drug and Toxicology Panels


name: Total number of doses | Patient | Drug toxicology


name: Test dose included in cumulative AUC | Patient | Drug toxicology


name: Infusion stop date and time | Patient | Drug toxicology


name: Infusion start date and time | Patient | Drug toxicology


name: Busulfan target concentration | Patient | Drug toxicology


name: Neutrophils.segmented/leukocytes | Blood | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Bone marrow | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Pleural fluid | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Synovial fluid | Hematology and Cell counts


name: Neutrophils.segmented/leukocytes | Stem cell product | Hematology and Cell counts


name: Neutrophils.band form/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Neutrophils.band form/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Neutrophils.band form/leukocytes | Pleural fluid | Hematology and Cell counts


name: Neutrophils.band form/leukocytes | Synovial fluid | Hematology and Cell counts


name: Neutrophils.band form/leukocytes | Stem cell product | Hematology and Cell counts


name: Neutrophils/leukocytes | Blood cord | Hematology and Cell counts


name: Neutrophils/leukocytes | Body fluid | Hematology and Cell counts


name: Neutrophils/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Neutrophils/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Neutrophils/leukocytes | Nose | Hematology and Cell counts


name: Neutrophils/leukocytes | Sputum | Hematology and Cell counts


name: Neutrophils/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Basophils/leukocytes | Amniotic fluid | Hematology and Cell counts


name: Basophils/leukocytes | Blood cord | Hematology and Cell counts


name: Basophils/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Basophils/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Basophils/leukocytes | Nose | Hematology and Cell counts


name: Basophils/leukocytes | Sputum | Hematology and Cell counts


name: Basophils/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Basophils/leukocytes | XXX | Hematology and Cell counts


name: Basophils/leukocytes | Fetus | Hematology and Cell counts


name: Basophils/leukocytes | Fetus | Blood | Hematology and Cell counts


name: Basophils/leukocytes | Stem cell product | Hematology and Cell counts


name: Eosinophils/leukocytes | Blood cord | Hematology and Cell counts


name: Eosinophils/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Eosinophils/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Eosinophils/leukocytes | Nose | Hematology and Cell counts


name: Eosinophils/leukocytes | Sputum | Hematology and Cell counts


name: Eosinophils/leukocytes | Stool | Hematology and Cell counts


name: Eosinophils/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Eosinophils/leukocytes | XXX | Hematology and Cell counts


name: Eosinophils/leukocytes | Stem cell product | Hematology and Cell counts


name: Metamyelocytes/leukocytes | Stem cell product | Hematology and Cell counts


name: Myelocytes/leukocytes | Body fluid | Hematology and Cell counts


name: Myelocytes/leukocytes | Stem cell product | Hematology and Cell counts


name: Promyelocytes/leukocytes | Stem cell product | Hematology and Cell counts


name: Leukocytes other/leukocytes | Blood | Hematology and Cell counts


name: Leukocytes other/leukocytes | Body fluid | Hematology and Cell counts


name: Leukocytes other/leukocytes | Bronchial | Hematology and Cell counts


name: Leukocytes other/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Leukocytes other/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Leukocytes other/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Smudge cells/leukocytes | Body fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Body fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Bronchial | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Pleural fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Synovial fluid | Hematology and Cell counts


name: Lymphocytes.variant/leukocytes | Stem cell product | Hematology and Cell counts


name: Lymphocytes/leukocytes | Blood cord | Hematology and Cell counts


name: Lymphocytes/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Lymphocytes/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Lymphocytes/leukocytes | Sputum | Hematology and Cell counts


name: Lymphocytes/leukocytes | Tissue and Smears | Hematology and Cell counts


name: Lymphocytes/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Lymphocytes/leukocytes | Fetus | Hematology and Cell counts


name: Lymphocytes/leukocytes | Fetus | Blood | Hematology and Cell counts


name: Lymphocytes/leukocytes | Stem cell product | Hematology and Cell counts


name: Macrophages/leukocytes | Bone marrow | Hematology and Cell counts


name: Macrophages/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Macrophages/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Monocytes/leukocytes | Blood cord | Hematology and Cell counts


name: Monocytes/leukocytes | Bronchial | Hematology and Cell counts


name: Monocytes/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Monocytes/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Monocytes/leukocytes | Urine | Hematology and Cell counts


name: Monocytes/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Monocytes/leukocytes | Stem cell product | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Blood | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Bone marrow | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Bronchial | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Pleural fluid | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Sputum | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Synovial fluid | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | Tissue and Smears | Hematology and Cell counts


name: Monocytes+Macrophages/leukocytes | XXX | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Blood | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Body fluid | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Bronchial | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Dialysis fluid peritoneal | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Gastric fluid | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Semen | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Fetus | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Fetus | Pleural fluid | Hematology and Cell counts


name: Mononuclear cells/leukocytes | Stem cell product | Hematology and Cell counts


name: Plasma cells/leukocytes | Blood cord | Hematology and Cell counts


name: Plasma cells/leukocytes | Bronchial | Hematology and Cell counts


name: Plasma cells/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Plasma cells/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Plasma cells/leukocytes | Pleural fluid | Hematology and Cell counts


name: Plasma cells/leukocytes | Synovial fluid | Hematology and Cell counts


name: Blasts/leukocytes | Blood cord | Hematology and Cell counts


name: Blasts/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Blasts/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Blasts/leukocytes | Pleural fluid | Hematology and Cell counts


name: Blasts/leukocytes | Synovial fluid | Hematology and Cell counts


name: Blasts/leukocytes | Fetus | Hematology and Cell counts


name: Blasts/leukocytes | Fetus | Blood | Hematology and Cell counts


name: Blasts/leukocytes | Stem cell product | Hematology and Cell counts


name: Unidentified cells/leukocytes | Blood | Hematology and Cell counts


name: Unidentified cells/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Unidentified cells/leukocytes | Pericardial fluid | Hematology and Cell counts


name: Unidentified cells/leukocytes | Peritoneal fluid | Hematology and Cell counts


name: Unidentified cells/leukocytes | Pleural fluid | Hematology and Cell counts


name: Unidentified cells/leukocytes | Synovial fluid | Hematology and Cell counts


name: Mesothelial cells/leukocytes | Blood | Hematology and Cell counts


name: Mesothelial cells/leukocytes | Cerebral spinal fluid | Hematology and Cell counts


name: Mesothelial cells/leukocytes | Dialysis fluid | Hematology and Cell counts


name: Mesothelial cells/leukocytes | Synovial fluid | Hematology and Cell counts


name: Mesothelial cells/leukocytes | Vitreous fluid | Hematology and Cell counts


name: Complement activity panel | Serum or Plasma | Hematology and Cell Count Panels


name: Cells.CD3/100 lymphocytes | Bone marrow | Cell markers


name: Cells.CD3/100 lymphocytes | XXX | Cell markers


name: Cells.CD20/100 cells | Bone marrow | Cell markers


name: Cells.CD2+CD3+/100 cells | Blood | Cell markers


name: Cells.CD2+CD3+/100 cells | Bone marrow | Cell markers


name: Cells.CD3-CD4+/100 cells | Blood | Cell markers


name: Cells.CD3-CD4+/100 cells | Bone marrow | Cell markers


name: Cells.CD3+CD4+CD8+/100 cells | Bone marrow | Cell markers


name: Cells.CD3+CD4+CD8+/100 cells | XXX | Cell markers


name: Cells.CD3+CD5+/100 cells | Blood | Cell markers


name: Cells.CD3+CD5+/100 cells | Bone marrow | Cell markers


name: Cells.CD3+CD5+/100 cells | XXX | Cell markers


name: Cells.CD3+CD7+/100 cells | Bone marrow | Cell markers


name: Cells.CD3+CD7+/100 cells | XXX | Cell markers


name: Cells.CD3+TCR gamma delta+/100 cells | Bone marrow | Cell markers


name: Cells.CD3-CD19+/100 cells | Bone marrow | Cell markers


name: Cells.CD4+CD8+/100 cells | Bone marrow | Cell markers


name: Cells.CD4+CD8+/100 cells | XXX | Cell markers


name: Cells.CD19+CD79b+/100 cells | XXX | Cell markers


name: Cells.CD19+Lambda+/100 cells | Bone marrow | Cell markers


name: Cells.CD19+FMC7+/100 cells | XXX | Cell markers


name: Cells.CD25+CD19+/100 cells | XXX | Cell markers


name: Lymphocytes/leukocytes | Blood | Cell markers


name: Lymphocytes/leukocytes | XXX | Cell markers


name: Chromosome analysis | Blood | Molecular pathology


name: CALR gene exon 9 targeted mutation analysis | Blood or Tissue | Mutations


name: Hereditary thyroid cancer multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary renal cancer multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary pancreatic cancer multigene analysis | Blood or Tissue | Molecular pathology


name: Breast Cancer recurrence risk multigene analysis | Tissue and Smears | Molecular pathology


name: Ulceration status | Tissue and Smears | Pathology


name: PD-L1 scoring method | Tissue and Smears | Pathology


name: Eosinophils/leukocytes | Urine | Urinalysis


name: Eosinophils/leukocytes | Urine sediment | Urinalysis


name: Stenosis degree | Tricuspid valve | Cardiac ultrasound


name: Circumference | Ankle | General body circumference


name: XR && RF|Upper extremity|Views|Laterality:ANY


name: Provision of patient generated medication list


name: Provision of medication list for public health and/or Centers for Disease Control and Prevention reporting


name: Provision of medication administration list


name: Education about Tribally Designated Housing Entity


name: Referral to Tribally Designated Housing Entity


name: Implementation of the Confidentiality, Universal Education, Empowerment, and Support intervention


name: Provision of discontinued medication list


name: Administration of coagulation factor replacement therapy


name: Administration of primary prophylactic coagulation replacement therapy


name: Administration of secondary prophylactic coagulation replacement therapy


name: Administration of tertiary prophylactic coagulation replacement therapy


name: Education about community solar subscription program


name: Education about household solar system installation assistance program


name: Evaluation of eligibility for household solar system installation assistance program


name: Assistance with application for household solar system installation assistance program


name: Assistance with application for community solar subscription program


name: Referral to household solar system installation assistance program


name: Referral to community solar subscription program


name: Thesaurus Biomedical Francais/Anglais (French translation of the Medical Subject Headings), 2025


name: Polish translation of the Medical Subject Headings, 2025


name: Descritores em Ciencias da Saude (Portuguese translation of the Medical Subject Headings), 2025


name: Russian translation of the Medical Subject Headings, 2025


name: Descritores en Ciencias de la Salud (Spanish translation of the Medical Subject Headings), 2025


name: MRI of right sacroiliac joint without and with contrast


name: Suture control of bleeding duodenal ulcer


name: Metathesaurus CMS Formulary Reference File, 2020


name: FDB MedKnowledge (formerly NDDF Plus), 2025_02_05


name: Veterans Health Administration National Drug File, 2025_01_31


name: Metathesaurus FDA Structured Product Labels, 2025_02_22


name: Anatomical Therapeutic Chemical Classification System, 2025_02_10


name: ALUMINUM CHLOROHYDRATE 24.5 g in 100 g TOPICAL SPRAY [Dry Active Sport 3.5oz]


name: AVOBENZONE 5 mg in 1 g / OCTINOXATE 50 mg in 1 g / OCTOCRYLENE 30 mg in 1 g / OCTISALATE 22 mg in 1 g TOPICAL STICK [Snap-On Racing Sunscreen Lip Balm]


name: HOMOSALATE 80 mg in 1 g / OCTOCRYLENE 80 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL STICK [Snap-On Racing Sunscreen]


name: OCTINOXATE 75 mg in 1 g / TITANIUM DIOXIDE 44.5 mg in 1 g / ZINC OXIDE 137.2 mg in 1 g TOPICAL CREAM [Camo CC Cream SPF30 Deep 500 W]


name: OCTOCRYLENE 3 g in 100 g / HOMOSALATE 5 g in 100 g / AVOBENZONE 2 g in 100 g / OCTISALATE 3 g in 100 g TOPICAL LIPSTICK [natural lip balm SPF15(unflavored) 01]


name: TITANIUM DIOXIDE 44.5 mg in 1 g / ZINC OXIDE 137.2 mg in 1 g / OCTINOXATE 75 mg in 1 g TOPICAL CREAM [Camo CC Cream SPF30 Deep 510 C]


name: TITANIUM DIOXIDE 80 mg in 1 g / ZINC OXIDE 38 mg in 1 g TOPICAL CREAM [Proceuticals Private Label by TiZO Tinted Facial Mineral Sunscreen Backbar]


name: CAPRYLIC/CAPRIC TRIGLYCERIDE 3 mg in 15 mL / GLYCERIN 5 mg in 15 mL CUTANEOUS CREAM


name: ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Sunceutical SPF 50 Mineral Body Cream]


name: ZINC OXIDE 25 g in 25 g TOPICAL CREAM [Sea-Laminaria Kelp Day Cream SPF 30]


name: HOMOSALATE 14.4 mg in 180 mL / GLYCERIN 10.9 mg in 180 mL / OCTOCRYLENE 9 mg in 180 mL / AVOBENZONE 5.4 mg in 180 mL / OCTISALATE 7.2 mg in 180 mL TOPICAL LOTION [St Moriz suncare body sunscreen spf30]


name: HOMOSALATE 18 mg in 180 mL / AVOBENZONE 5.4 mg in 180 mL / OCTISALATE 7.2 mg in 180 mL / OCTOCRYLENE 18 mg in 180 mL TOPICAL LOTION [St Moriz suncare body sunscreen spf50]


name: ALUMINUM SESQUICHLOROHYDRATE 17.6 g in 100 g TOPICAL SPRAY [Dry Cool Sport 3.5oz]


name: OCTINOXATE 60 mg in 1 mL / ZINC OXIDE 29.4 mg in 1 mL TOPICAL EMULSION [LBEL CONCENTRE GLOBAL ANTI AGING SERUM FOUNDATION SPF 15 ALMENDRA 230N]


name: OCTOCRYLENE 5.4 mg in 180 mL / OCTISALATE 9 mg in 180 mL / TITANIUM DIOXIDE 5.4 mg in 180 mL TOPICAL LOTION [St Moriz suncare face sunscreen spf30]


name: OCTOCRYLENE 7 g in 100 g / AVOBENZONE 2 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL GEL [BaliBody SPF15 Bronze Shimmering Tanning Gel]


name: OCTOCRYLENE 9 mg in 180 mL / HOMOSALATE 16.2 mg in 180 mL / AVOBENZONE 5.4 mg in 180 mL / OCTISALATE 7.2 mg in 180 mL TOPICAL LOTION [St Moriz suncare face sunscreen spf50]


name: TITANIUM DIOXIDE 7.75 g in 100 g / ZINC OXIDE 10 g in 100 g TOPICAL CREAM [EVEN DEFENSE Mineral Sunscreen Broad Spectrum SPF 30]


name: SODIUM HYALURONATE 200 mg in 30 mL / PANTHENOL 600 mg in 30 mL / 3-O-ETHYL ASCORBIC ACID 3000 mg in 30 mL / .ALPHA.-TOCOPHEROL ACETATE 600 mg in 30 mL / ALPHA-ARBUTIN 600 mg in 30 mL / LICORICE 0.6 mg in 30 mL / FERULIC ACID 150 mg in 30 mL TOPICAL LIQUID [Vitamin C and E Ferulic Glow Potion]


name: ZINC OXIDE 19.6 mg in 1 g / OCTINOXATE 50 mg in 1 g TOPICAL EMULSION [LBEL CONCENTRE GLOBAL ANTI AGING SERUM CONCEALER SPF 15 EYES FACE ALMENDRA 230]


name: Zinc Oxide 125 mg in 1 mL TOPICAL LOTION [SOS Face Guard Broad Spectrum Sunscreen SPF 30]


name: OCTINOXATE 7.5 g in 60 g TOPICAL EMULSION [Sunscreen Karina Skin Care SPF 15]


name: OCTISALATE 10 mg in 1 mL / HOMOSALATE 73 mg in 1 mL / OCTINOXATE 74.9 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [DECORTE SUN SHELTER MULTI PROTECTION Sunscreen SPF 50 Broad Spectrum]


name: OCTOCRYLENE 8 g in 100 g / AVOBENZONE 3 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL CREAM [Neptune Ave. High Dive Barrier Repair Moisturizer Broad Spectrum SPF 50]


name: ZINC OXIDE 21.8 g in 100 g TOPICAL LIQUID [Sun Serum Drops]


name: {1 (1 ML mirikizumab-mrkz 100 MG/ML Auto-Injector) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Auto-Injector) } Pack


name: {1 (1 ML mirikizumab-mrkz 100 MG/ML Auto-Injector [Omvoh]) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Auto-Injector [Omvoh]) } Pack [Omvoh Prefilled Pen 300 MG Dose Carton]


name: {1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) } Pack


name: {1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh]) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh]) } Pack [Omvoh Prefilled Syringe 300 MG Dose Carton]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL CREAM [Jil Goorman Skincare Sun Guard SPF 30]


name: TITANIUM DIOXIDE 114 mg in 1 g / ZINC OXIDE 55 mg in 1 g TOPICAL CREAM [Kandesn CC Cream Sunscreen Broad Spectrum SPF 30 Rich]


name: ZINC OXIDE 10 mg in 100 mg TOPICAL CREAM [Ceile SPF 30 prime PROTECT Broad Spectrum SPF 30 Sunscreen]


name: ZINC OXIDE 24 g in 100 mL TOPICAL CREAM [FRE BRONZE ME Sun-Kissed Mineral Sunscreen SPF 50]


name: ZINC OXIDE 150 mg in 1 mL TOPICAL LIQUID [FRE PLUMP ME PEPTIDE LIP TINT CASSIS SPF 30]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDRATE ANHYDROUS 16 g in 100 g TOPICAL GEL [Secret Cool Waterlily Clear]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 16 g in 100 g TOPICAL GEL [Secret Mountain Air Clear]


name: AVOBENZONE 0.918 g in 30 mL / OCTINOXATE 2.038 g in 30 mL / OCTISALATE 1.377 g in 30 mL / OCTOCRYLENE 0.612 g in 30 mL TOPICAL CREAM [CHARLOTTE TILBURY Broad Spectrum SPF 50 Sunscreen Invisible UV Flawless Poreless Primer]


name: AVOBENZONE 20 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OCTOCRYLENE 17 mg in 1 mL TOPICAL CREAM [RODAN - FIELDS ESSENTIALS Body Sunscreen BROAD SPECTRUM SPF 30]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 8 g in 100 g / OCTOCRYLENE 10 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL STICK [Hydraboost Lip Treatment]


name: AVOBENZONE 3 g in 100 g / OCTOCRYLENE 10 g in 100 g / OCTISALATE 5 g in 100 g / HOMOSALATE 15 g in 100 g TOPICAL STICK [Meijer SPF 50 Sunscreen]


name: HOMOSALATE 4 g in 100 g / OCTISALATE 4 g in 100 g / OCTOCRYLENE 3 g in 100 g / AVOBENZONE 2 g in 100 g TOPICAL LOTION [BANANA BOAT]


name: HOMOSALATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 26 mg in 1 mL / OXYBENZONE 20 mg in 1 mL TOPICAL CREAM [StriVectin-SH NIA-114 UVA UVB Shields SPF 30]


name: OCTOCRYLENE 5 g in 100 g / HOMOSALATE 7.5 g in 100 g / AVOBENZONE 2.7 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [BANANA BOAT]


name: OCTOCRYLENE 5.7 g in 100 g / OCTISALATE 4.5 g in 100 g / AVOBENZONE 1.9 g in 100 g TOPICAL AEROSOL, SPRAY [BANANA BOAT]


name: OCTOCRYLENE 70 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [Garnier SkinActive Vitamin(E) C UV Brightening Daily Broad Spectrum SPF 30]


name: ZINC OXIDE 10.9 g in 100 g TOPICAL LOTION [Safe Sea SPF 30]


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Xelria Fe 28 Day]


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Feirza 1/20 28 Day]


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Feirza 1.5/30 28 Day]


name: bupivacaine/lidocaine/triamcinolone 0.25%-1%-40 mg/mL injectable kit


name: BD Safetyglide 1 mL 27G x 3/8" TB Syringe


name: Heali Kin Tape Infused Magnesium And Menthol


name: Heali Kinesiology Tape For Plantar Fasciitis


name: Heali Kinesiology Tape Pain Relief Beige


name: Heali Kinesiology Tape Pain Relief Black


name: Heali Pro Kinesiology Tape Blue Splatter


name: Omnipod 5 DexG7G6 Pods (Gen 5) Govt Use Only


name: Seni Active Classic Plus Underwear Large


name: Seni Active Classic Plus Underwear Medium


name: Seni Active Classic Plus Underwear X-Large


name: Seni Active Super Plus Underwear X-Large


name: Seni Active Super Plus Underwear XX-Large


name: Seni Man Active Light Bladder Control Guard


name: Seni Soft Classic Dry Underpads Large Surface


name: Seni Soft Super Dry Underpads Large Surface


name: Other antineoplastic agents (cont.) in ATC


name: emtricitabine, tenofovir alafenamide and dolutegravir


name: pyrazinamide, ethambutol, isoniazid and lomefloxacin


name: pyrazinamide, ethambutol, protionamide and lomefloxacin


name: rifabutin, pyrazinamide and protionamide


name: rifampicin, pyrazinamide, isoniazid and levofloxacin


name: Isocitrate dehydrogenase (IDH) inhibitors, antineoplastic


name: {5 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ethinyl estradiol 0.03 MG / norethindrone acetate 1 MG Oral Tablet) / 9 (ethinyl estradiol 0.035 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Xarah Fe 28 Day]


name: pyridoxine hydrochloride and pyridoxal-5-phosphate (vitamin B-6)


name: ZINC OXIDE 140 mg in 1 g / TITANIUM DIOXIDE 37 mg in 1 g TOPICAL LOTION [Evereden Fluid Silk Mineral Sunscreen PRO SPF50]


name: ZINC OXIDE 188 mg in 1 g TOPICAL SPONGE [Tri-water sheer mineral sunscreen cushion SPF30]


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 19 g in 100 g TOPICAL CREAM [Old Spice Sweat Defense Deep Sea]


name: AVOBENZONE 3 mg in 100 mg / HOMOSALATE 10 mg in 100 mg / OCTISALATE 5 mg in 100 mg / OCTOCRYLENE 10 mg in 100 mg TOPICAL OINTMENT [Everyday Humans Sunscreen Lip Balm Broad Spectrum SPF30]


name: ZINC OXIDE 22.1 g in 100 g TOPICAL POWDER [Brush On Block SPF 30 Mineral Powder Translucent Zinc Only-Refill]


name: STIMULATOR,NEUROMUSCULAR GEKO DEVICE T-3


name: STIMULATOR,NEUROMUSCULAR GEKO DEVICE W-3


name: TRACH TUBE,SZ 6 BIVONA SMITHS #60AFHXL60


name: CATHERIZATION SET,W/O CATH APOGEE PLUS #6100A


name: DRESSING,ZETUVIT PLUS SILICONE BORDER 5IN X 6IN #413908


name: CATHETER,INTERMITTENT COUDE 12FR COLOPLAST #20102


name: OCTINOXATE 1.05 g in 15 g / OCTISALATE 0.67 g in 15 g / OCTOCRYLENE 0.3 g in 15 g TOPICAL STICK [OrgaPlus Ultra Pure Sun EX 15g]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL CREAM [Atlanta Acne Specialist Everyday Sunscreen SPF 30]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL CREAM [Seven Thirty Daily Habit Broad Spectrum SPF 30]


name: ZINC OXIDE 12 g in 100 mL TOPICAL LOTION [Brush On Block Sheer Genius SPF 50 Mineral Moisture]


name: ZINC OXIDE 150 mg in 1 g TOPICAL CREAM [TiZO Tinted Moisturizing Serum - Deep]


name: Ultra-Fine U-100 12.7mm 30G 0.3mL Insulin Syringe


name: Ultra-Fine U-100 12.7mm 30G 0.5mL Insulin Syringe


name: Ultra-Fine U-100 12.7mm 30G 1mL Insulin Syringe


name: Ultra-Fine U-100 6mm 31G 0.3mL Insulin Syringe


name: Ultra-Fine U-100 6mm 31G 0.5mL Insulin Syringe


name: Ultra-Fine U-100 6mm 31G 1mL Insulin Syringe


name: Ultra-Fine U-100 8mm 31G 0.3mL Insulin Syringe


name: Ultra-Fine U-100 8mm 31G 0.5mL Insulin Syringe


name: Ultra-Fine U-100 8mm 31G 1mL Insulin Syringe


name: embecta U-100 12.7mm 28G 1mL Insulin Syringe


name: embecta U-100 16mm 27G 1mL Insulin Syringe


name: SUN BURNT Advanced Sun Recovery Daily Moisturizing Lotion


name: syringe with cannula, disposable, 1 mL and atomizer NASAL COMBINATION PACKAGE (EA)


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 16 g in 100 g TOPICAL GEL [Secret Light Ocean Breeze Clear]


name: ZINC OXIDE 3.4 g in 100 mL / TITANIUM DIOXIDE 4.5 g in 100 mL TOPICAL OIL [Brush On Block Sun Shine SPF 30 Protective Lip Oil Peony Tint]


name: {24 (ethinyl estradiol 0.025 MG / norethindrone 0.8 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Galbriela 28 Day]


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Orquidea 28 Day]


name: {21 (ethinyl estradiol 0.035 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Valtya 1/35 28 Day]


name: {21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Valtya 1/50 28 Day]


name: Cream, Multi Ingredient Topical application Cream [PALMER'S VITAMIN E CONCENTRATED]


name: Cream, Multi Ingredient Topical application Cream [PALMER'S VITAMIN E BODY BUTTER]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-15%-5%-10% Topical application Lotion [QUALITY CHOICE BABY SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-15%-5%-6% Topical application Lotion [QUALITY CHOICE ULTIMATE SUNSCREEN]


name: Betamethasone Acetate/Betamethasone Sodium Phosphate;Iodixanol;Isopropyl Alcohol;Lidocaine Hydrochloride;Povidone Iodine 6 MG/1 ML; 320 MG/1 ML; 70%; 1%; 10% Multiple Routes Kit


name: betamethasone / florfenicol / terbinafine


name: TITANIUM DIOXIDE 100 mg in 1 mL / ZINC OXIDE 80 mg in 1 mL TOPICAL CREAM [Aruba Aloe Broad Spectrum SPF 30 Mineral Sunscreen]


name: TITANIUM DIOXIDE 3.6 g in 100 mL / ZINC OXIDE 2.34 g in 100 mL TOPICAL LOTION [Tula Skincare Protect and Deflect Mineral Sunscreen Broad Spectrum SPF 30]


name: OCTISALATE 5 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 7 g in 100 g TOPICAL CREAM [Tula 24-7 Moisture Plus SPF 30 Hydrating Day with Sunscreen Broad Spectrum SPF 30]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 17 g in 100 g TOPICAL STICK [Old Spice Alpine]


name: AVOBENZONE 30 mg in 0.001 L / OCTISALATE 50 mg in 0.001 L / OCTOCRYLENE 70 mg in 0.001 L TOPICAL CREAM [Pacific Mango Sunscreen SPF 30]


name: ETHYLHEXYL METHOXYCINNAMATE 8.49405 g in 100 mL / TITANIUM DIOXIDE 3.9 g in 100 mL / ALUMINUM HYDROXIDE 0.6 g in 100 mL / ETHYLHEXYL SALICYLATE 4 g in 100 mL / PHENYLBENZIMIDAZOLE SULFONIC ACID 1 g in 100 mL / ZINC OXIDE 10.45 g in 100 mL TRANSDERMAL CREAM


name: LIDOCAINE HYDROCHLORIDE 3.5 mg in 100 mL TOPICAL LIQUID [Sunset Novelties Herquake]


name: ZINC OXIDE 13.1 g in 100 mL TOPICAL LIQUID [Skin Solution Multi-Serum Skin Tint SPF 40]


name: KOJIC DIPALMITATE 0.6 g in 30 g / CYCLOMETHICONE 0.6 g in 30 g / ACRYLAMIDE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER (120000 MPA.S AT 1%) 0.24 g in 30 g / DIMETHICONE 0.6 g in 30 g / XYLITYLGLUCOSIDE 0.3 g in 30 g / TRIETHANOLAMINE 0.3 g in 30 g / CAPRYLIC/CAPRIC TRIGLYCERIDE 0.75 g in 30 g / DIETHYLENE GLYCOL DISTEARATE 0.6 g in 30 g / CETYL ALCOHOL 0.3 g in 30 g / EDTA 0.03 g in 30 g / ALLANTOIN 0.09 g in 30 g TOPICAL CREAM [Beaute]


name: TITANIUM DIOXIDE 4 g in 100 mL / PHENYLBENZIMIDAZOLE SULFONIC ACID 3.2 g in 100 mL / HOMOSALATE 1 g in 100 mL / ZINC OXIDE 0.6 g in 100 mL / ETHYLHEXYL SALICYLATE 5 g in 100 mL CUTANEOUS CREAM


name: TITANIUM DIOXIDE 2.76 g in 100 mL / ETHYLHEXYL SALICYLATE 5 g in 100 mL / PHENYLBENZIMIDAZOLE SULFONIC ACID 3.2 g in 100 mL / ZINC OXIDE 2.85 g in 100 mL CUTANEOUS CREAM


name: OCTINOXATE 75 mg in 1 g / MERADIMATE 50 mg in 1 g / OXYBENZONE 30 mg in 1 g / OCTISALATE 50 mg in 1 g CUTANEOUS LOTION [Pro-Tect Sports Sunscreen SPF 20]


name: OCTINOXATE 75 mg in 1 mL / TITANIUM DIOXIDE 50 mg in 1 mL TOPICAL LIQUID [Laura Mercier Flawless Skin Daily Face Shield SPF 40]


name: OCTOCRYLENE 56 mg in 1 g / AVOBENZONE 30 mg in 1 g / HOMOSALATE 105 mg in 1 g / OCTISALATE 35 mg in 1 g TOPICAL AEROSOL, SPRAY [Bondi Sands Fragrance Free Face SPF 50 Sunscreen Mist]


name: ZINC OXIDE 25 g in 100 g TOPICAL CREAM [Sky and Sol Body Sunscreen]


name: ZINC OXIDE 25 g in 100 g TOPICAL CREAM [Sky and Sol Sunscreen SPF 50]


name: ASCORBIC ACID 20 mg in 100 mL TOPICAL LIQUID [Srripo 20% VITAMIN C SERUM]


name: FENBENDAZOLE 250 g in 250 g NOT APPLICABLE POWDER


name: FENBENDAZOLE 500 g in 500 g NOT APPLICABLE POWDER


name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [rms SunCoverup Super Tint]


name: ZINC OXIDE 25 g in 100 g TOPICAL OINTMENT [Sky and Sol Intense Healing Lip Jelly]


name: {6 (nirmatrelvir 150 MG Oral Tablet) / 5 (ritonavir 100 MG Oral Tablet) } Pack [Paxlovid 300 MG /100 MG ; 150 MG / 100 MG Dose Pack]


name: ZINC OXIDE 142.8 mg in 1 mL TOPICAL LOTION [Well People Daygleamer Liquid Mineral Sunscreen SPF 34]


name: ZINC OXIDE 24.05 g in 100 g TOPICAL CREAM [Hi papa KIDS MINERAL FACE SUNSCREEN]


name: ZINC OXIDE 25 g in 100 g CUTANEOUS CREAM


name: PHENOXYBENZAMINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 90 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL CREAM [Purito Sunday Adventure Sunscreen SPF 50, 50 mL]


name: HOMOSALATE 6 g in 50 mL / OCTOCRYLENE 5 g in 50 mL / OCTISALATE 4.5 g in 50 mL / ZINC OXIDE 10.38 g in 50 mL TOPICAL CREAM [Cell Fusion C Laser UV Defense Sunscreen Broad Spectrum SPF 50]


name: HOMOSALATE 7.3 g in 50 mL / OCTOCRYLENE 9 g in 50 mL / OCTISALATE 5 g in 50 mL / AVOBENZONE 3 g in 50 mL TOPICAL CREAM [Cell Fusion C Aquatica UV Defense Sunscreen Broad Spectrum SPF 50]


name: HOMOSALATE 9.5 g in 100 g / OCTOCRYLENE 5 g in 100 g / OCTISALATE 4.5 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL STICK [Cell Fusion C Airy Stick Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 2.7 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL SPRAY [Smart Care SPORT ultra CLEAR SUNSCREEN SPF 50]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL SPRAY [Smart Care Barbie KIDS SUNSCREEN SPF 50]


name: AVOBENZONE 3 g in 100 g / OCTINOXATE 7.5 g in 100 g / OCTISALATE 5 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL CREAM [YOUR TINTED MOISTURIZER HYDRATING ANTI AGING BROAD SPECTRUM SPF 30]


name: TITANIUM DIOXIDE 4.5 g in 100 g / ZINC OXIDE 6.5 g in 100 g TOPICAL LOTION [Smart Care SPORT ultra SUNSCREEN SPF 50]


name: ZINC OXIDE 16.1 g in 100 g TOPICAL CREAM [Truskin SPF 30 Mineral Sunscreen Facial Serum]


name: ZINC OXIDE 188 mg in 1 g TOPICAL LOTION [Ultra sheer mineral sunscreen PRO SPF30]


name: ZINC OXIDE 21.7 g in 100 mL TOPICAL LOTION [DreamBeam Sunscreen Sunlit]


name: ZINC OXIDE 25 g in 100 g TOPICAL CREAM [Sky and Sol Face Sunscreen SPF 50]


name: ZINC OXIDE 7.5 g in 100 mL TOPICAL LOTION [Revealer Skin-Improving Foundation]


name: ZINC OXIDE 9.4 mg in 100 mL TOPICAL LOTION [Daily Sunscreen Broad Spectrum SPF 30 UVA UVB]


name: TURMERIC 0.02 g in 100 g / LEMON 0.02 g in 100 g TOPICAL SOAP [HANCHOBIT Lemon Turmeric Kojic Acid Brightening]


name: ZINC OXIDE 67 mg in 1 mL TOPICAL EMULSION [Dolce and Gabbana Blueberry Nutri Tint SPF 20 10N Light Medium]


name: ALUMINUM CHLOROHYDRATE 100 mg in 1 g TOPICAL AEROSOL, SPRAY [Brut Classic Antiperspirant and Deodorant]


name: OCTINOXATE 7.5 g in 1 mL / OXYBENZONE 6 g in 1 mL / OCTISALATE 5 g in 1 mL TOPICAL LOTION [Avon Skin-So-Soft Bug Guard plus SPF 30 Sunscreen Gentle Breeze Insect Repellent Sunscreen]


name: ZINC OXIDE 19 g in 50 mL TOPICAL CREAM [Cell Fusion C Derma UV Mineral Sunscreen Broad Spectrum SPF 50]


name: CURCUMA LONGA (TURMERIC) ROOT POWDER 5 g in 100 mL EXTRACORPOREAL AEROSOL, FOAM [FluMisch Turmeric Kojic Acid Facial Cleanser]


name: KOJIC ACID 1 g in 100 mL / ASCORBIC ACID 2 g in 100 mL / GLUTATHIONE 1 g in 100 mL / NIACINAMIDE 1 g in 100 mL EXTRACORPOREAL LIQUID [FEELSHION Dark Spot Remover Serum]


name: TOCOPHEROL 1 g in 100 mL / BUTYROSPERMUM PARKII (SHEA) BUTTER 3 g in 100 mL / PRUNUS ARMENIACA (APRICOT) KERNEL EXTRACT 2 g in 100 mL / NIACINAMIDE 0.05 g in 100 mL / BUTYLENE GLYCOL 5 g in 100 mL / ASCORBIC ACID 0.05 g in 100 mL EXTRACORPOREAL CREAM [QIDILA Whitening Skin Lightening Cream]


name: ZINC OXIDE 170 mg in 1 mL TOPICAL CREAM [Dr Loretta Universal Glow Daily Defense SPF 40]


name: ZINC OXIDE 220 mg in 1 g TOPICAL LIQUID [Sheer Tint Mineral SPF Serum - Medium Medium]


name: meningococcal group B vaccine / Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL SPRAY [Smart Care SPIDER-MAN KIDS SUNSCREEN SPF 50]


name: Living Arrangements:-:RptPeriod:^Patient:-:CMS Assessment (105176-2)


name: I have indicated all the devices needed:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Functional assessment standardized items (FASI) - v1.2:-:RptPeriod:^Patient:-:CMS Assessment


name: Functional assessment standardized items (FASI) - v1.2


name: Outcome and assessment information set (OASIS) form - version E1 - Start of Care:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Start of Care


name: Outcome and assessment information set (OASIS) form - version E1:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1


name: Outcome and assessment information set (OASIS) form - version E1 - Resumption of Care:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Resumption of Care


name: Outcome and assessment information set (OASIS) form - version E1 - Death at Home:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Death at Home


name: Outcome and assessment information set (OASIS) form - version E1 - Transfer to an Inpatient Facility:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Transfer to an Inpatient Facility


name: Outcome and assessment information set (OASIS) form - version E1 - Follow Up:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Follow Up


name: Outcome and assessment information set (OASIS) form - version E1 - Discharge from Agency:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E1 - Discharge from Agency


name: Hospice Outcomes and Patient Evaluation (HOPE) Admission v1.0:-:RptPeriod:^Patient:-:CMS Assessment


name: Hospice Outcomes and Patient Evaluation (HOPE) Admission v1.0


name: Hospice Outcomes and Patient Evaluation (HOPE) v1.0:-:RptPeriod:^Patient:-:CMS Assessment


name: Hospice Outcomes and Patient Evaluation (HOPE) v1.0


name: Hospice Outcomes and Patient Evaluation (HOPE) Discharge v1.0:-:RptPeriod:^Patient:-:CMS Assessment


name: Hospice Outcomes and Patient Evaluation (HOPE) Discharge v1.0


name: Site of Service at Admission:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Patient ZIP Code:Loc:RptPeriod:^Patient:Nom:CMS Assessment


name: Date the patient or responsible party was first asked about preference regarding the use of CPR:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date the patient or responsible party was first asked about preference regarding the use of CPR


name: Was the patient or responsible party asked about preference regarding the use of cardiopulmonary resuscitation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient or responsible party asked about preference regarding the use of cardiopulmonary resuscitation


name: Other Life-Sustaining Treatment Preferences:-:RptPeriod:^Patient:-:CMS Assessment


name: Was the patient or responsible party asked about preferences regarding life-sustaining treatments other than CPR:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient or responsible party asked about preferences regarding life-sustaining treatments other than CPR


name: Date the patient or responsible party was first asked about preferences regarding life-sustaining treatments other than CPR:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date the patient or responsible party was first asked about preferences regarding life-sustaining treatments other than CPR


name: Date the patient and or caregiver was first asked about spiritual or existential concerns:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date the patient and or caregiver was first asked about spiritual or existential concerns


name: Was the patient and or caregiver asked about spiritual or existential concerns:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient and or caregiver asked about spiritual or existential concerns


name: Spiritual or Existential Concerns:-:RptPeriod:^Patient:-:CMS Assessment


name: Date the patient or responsible party was first asked about preference regarding hospitalization:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date the patient or responsible party was first asked about preference regarding hospitalization


name: Was the patient or responsible party asked about preference regarding hospitalization:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient or responsible party asked about preference regarding hospitalization


name: Comorbidities and Co-existing Conditions:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Death is Imminent:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient screened for pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Date of first screening for pain:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Patient's pain severity:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a comprehensive pain assessment done:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a comprehensive pain assessment done


name: Type of standardized pain tool used:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Pain Active Problem:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Comprehensive Pain Assessment:-:RptPeriod:^Patient:-:CMS Assessment


name: Date of comprehensive pain assessment:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Comprehensive pain assessment included:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Screening for Shortness of Breath:-:RptPeriod:^Patient:-:CMS Assessment


name: Was the patient screened for shortness of breath:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was the patient screened for shortness of breath


name: Date of first screening for shortness of breath:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date of first screening for shortness of breath


name: Did the screening indicate the patient had shortness of breath:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Did the screening indicate the patient had shortness of breath


name: Treatment for Shortness of Breath:-:RptPeriod:^Patient:-:CMS Assessment


name: Was treatment for shortness of breath initiated:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was treatment for shortness of breath initiated


name: Date treatment for shortness of breath initiated:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date treatment for shortness of breath initiated


name: Date of symptom impact screening:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Was a symptom impact screening completed:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a symptom impact screening completed


name: Symptom Impact Screening:-:RptPeriod:^Patient:-:CMS Assessment


name: Symptom Impact - Pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Shortness of breath:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Anxiety:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Vomiting:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Nausea:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Diarrhea:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Constipation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Impact - Agitation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Agitation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Constipation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Diarrhea:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Vomiting:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Nausea:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Anxiety:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Shortness of breath:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact - Pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Symptom Follow-up Visit:-:RptPeriod:^Patient:-:CMS Assessment


name: Was an in-person SFV completed:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Date of in-person SFV:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Reason SFV Not Completed:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SFV Symptom Impact:-:RptPeriod:^Patient:-:CMS Assessment


name: Skin Conditions. Does the patient have one or more skin conditions:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Skin Conditions. Does the patient have one or more skin conditions


name: Types of Skin Conditions:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Skin and Ulcer or Injury Treatments:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Date bowel regimen initiated or continued:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date bowel regimen initiated or continued


name: Was a bowel regimen initiated or continued:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a bowel regimen initiated or continued


name: Date PRN opioid initiated or continued:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Was a PRN opioid initiated or continued:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a scheduled opioid initiated or continued:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Was a scheduled opioid initiated or continued


name: Date scheduled opioid initiated or continued:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date scheduled opioid initiated or continued


name: Reason for Discharge:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Hospice Outcomes and Patient Evaluation (HOPE) Update Visit v1.0:-:RptPeriod:^Patient:-:CMS Assessment


name: Hospice Outcomes and Patient Evaluation (HOPE) Update Visit v1.0


name: Administrative information:-:RptPeriod:^Patient:-:CMS Assessment (106935-0)


name: Hospice Home Care (Routine Home Care (RHC)) Provided in a Hospice Facility


name: Inpatient Hospice Facility (General Inpatient (GIP))


name: Nursing Long Term Care (LTC) or Non-Skilled Nursing Facility (NF)


name: Cardiovascular (excluding heart failure)


name: Congregate home (e.g., assisted living or residential care home)


name: Inpatient facility (e.g., skilled nursing facility, nursing home, inpatient hospice, hospital)


name: Around-the-clock (24 hours a day with few exceptions)


name: Regular daytime (all day every day with few exceptions)


name: Regular nighttime (all night every night with few exceptions)


name: angioplasty of superior mesenteric artery (treatment)


name: angioplasty of common femoral artery (treatment)


name: angioplasty of celiac artery (treatment)


name: angioplasty of popliteal artery (treatment)


name: SNOMEDCT_US_2025_03_01 to ICD10CM_2025 Mappings


name: percutaneous transluminal angioplasty of renal artery (treatment)


name: percutaneous transluminal balloon angioplasty of renal artery


name: Healthcare Common Procedure Coding System, 2025_04


name: HCPCS Version of Current Procedural Terminology (CPT), 2025_04


name: Manual transanal irrigation system, includes water reservoir, pump, tubing, and accessories, without catheter, any type


name: Gradient compression wrap with adjustable straps, full leg, each, custom


name: Gradient compression wrap with adjustable straps, foot, each, custom


name: Gradient compression wrap with adjustable straps, below knee, each, custom


name: Gradient compression wrap with adjustable straps, arm, each, custom


name: Gradient compression garment, not otherwise specified, for nighttime use, each


name: Gradient compression garment, not otherwise specified, for daytime use, each


name: Gradient compression wrap with adjustable straps, above knee, each, custom


name: Simulation angiogram with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the angiogram, for subsequent therapeutic radioembolization of tumors


name: Bronchoscopy, rigid or flexible, non-thermal transbronchial ablation of lesion(s) by pulsed electric field (pef) energy, including fluoroscopic and/or ultrasound guidance, when performed, with computed tomography acquisition(s) and 3d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) of all mediastinal and/or hilar lymph node stations or structures, and therapeutic intervention(s)


name: 3d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography and/or magnetic resonance imaging with report


name: Wheelchair transportation securement system, any type includes all components and accessories


name: Wheelchair transit securement system, includes all components and accessories


name: Wheelchair accessory, manual swingaway, retractable or removable mounting hardware used with joystick or other drive control interface


name: Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for headrest, cushioned, any type


name: Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for lateral trunk or hip support, any type


name: Static progressive stretch finger device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories


name: Quantitative software measurements of cardiac volume, cardiac chambers volumes and left ventricular wall mass derived from ct scan(s) data of the chest/heart (with or without contrast)


name: 3d radiodensity-value bone imaging, algorithm derived, from previous magnetic resonance examination of the same anatomy


name: Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique


name: Cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise


name: Ankle foot orthosis, rigid anterior tibial section, total carbon fiber or equal material, prefabricated, off-the-shelf


name: Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic or other material, prefabricated, off-the-shelf


name: Endoskeletal knee-shin system, single axis, electromechanical swing and stance phase control, with or without shock absorption and stance extension damping


name: Partial hand including fingers, flexible or non-flexible interface, endoskeletal system, molded to patient model, for use without external power, not including inserts described by l6692


name: Upper extremity addition, test socket/interface, partial hand including fingers


name: Upper extremity addition, external frame, partial hand including fingers


name: Replacement socket/interface, partial hand including fingers, molded to patient model, for use with or without external power


name: Addition to upper extremity prosthesis, partial hand including fingers, ultralight material (titanium, carbon fiber or equal)


name: Addition to upper extremity prosthesis, partial hand including fingers, acrylic material


name: Immediate post-surgical or early fitting, application of initial rigid dressing, including fitting alignment and suspension of components, and one cast change, partial hand including fingers


name: Addition to upper extremity prosthesis, lock mechanism, excludes socket insert